Xiamen High-Tech Innovation Center logo

Xiamen High-Tech Innovation Center

Asia, Fujian, China, Xiamen

Description

Xiamen High-Tech Innovation Center provides investment and financing services for small and medium-sized science and technology enterprises.

Investor Profile

Xiamen High-Tech Innovation Center has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (33%)
  • Seed (33%)
  • Series A (33%)

Country Focus

  • China (100%)

Industry Focus

  • Medical
  • Biotechnology
  • Genetics
  • Health Care
  • Medical Device
  • Aerospace
  • Electronics
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xiamen High-Tech Innovation Center frequently co-invest with?

WL
North America, Washington, United States, Seattle
Co-Investments: 1
KC
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Beijing Science Sun Pharmaceutical
Asia, Beijing, China, Beijing Shi
Co-Investments: 1
Sirnaomics
North America, Maryland, United States, Gaithersburg
Co-Investments: 1
Kexi Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Green Pine Capital Partners
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1

What are some of recent deals done by Xiamen High-Tech Innovation Center?

Zhongkexifu

Xiamen, Zhejiang, China

Zhongkexifu focuses on developing, testing, and industrializing of new fluorinated carbon materials

Advanced MaterialsIndustrialUsability Testing
AngelApr 25, 2025
Zhongxin New Carbon

Xiamen, Fujian, China

Zhongxin New Carbon is a company specializes in the research, development, and production of high-performance carbon materials.

AerospaceElectronicsSemiconductor
Series AFeb 27, 2025
Huayuan Regenerative Medicine

Shenzhen, Guangdong, China

Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.

Health CareMedicalMedical Device
SeedNov 23, 2023
Baisios

Fengtai, Beijing, China

Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.

BiotechnologyGeneticsMedical
Series BNov 1, 2023